Latest News

DuPont (DD) Q4 2025 Earnings Call Transcript

If you're searching for dividend stocks in the energy sector, these two stocks are solid choices.

This growth stock can pleasantly surprise investors.

AMD has been the better stock pick as of late.

Social Security is a complex program.

Silver and gold prices crashed abruptly on Jan. 30.

After a blowout 2025, Roku needs to regain its winning ways this earnings season.

Buying Apple stock might be a good way to cushion your portfolio against an AI sell-off.

Vanguard offers a wide array of quality, ultra-cheap ETFs that are great for investors. But I'd steer clear of this one in particular.

Electronic components manufacturer CTS Corporation (NYSE:CTS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.7% year on year to $137.3 million. The company’s full-year revenue guidance of $565 million at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.62 per share was 3.3% above analysts’ consensus estimates.

The Broadcom stock price has rebounded in the past few days, moving from a low of $295 last week to $345 today as investors cheer the recent plans for AI spending.

It sounds great in theory, but it's much more difficult in practice.

American motorcycle manufacturing company Harley-Davidson (NYSE:HOG) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 27.9% year on year to $496 million. Its GAAP loss of $2.44 per share was significantly below analysts’ consensus estimates.

Oracle stock was slightly higher Tuesday after starting the week with its best trading day in five months.

It's been a challenging few months for Bitcoin's biggest supporters.

The S&P 500 remains locked into the upper realms of its historic price.

The stock is down more than 30% from its 52-week high despite another insane quarter of growth.

AstraZeneca stock rose moderately Tuesday morning on better-than-expected sales and profit in the fourth quarter.

The company is looking to take on Regeneron and Sanofi's blockbuster, Dupixent, in eczema treatment.

Long-time Bitcoin investors have seen this story before. After every crash comes a record-setting recovery.